0001628280-24-000294.txt : 20240103
0001628280-24-000294.hdr.sgml : 20240103
20240103181825
ACCESSION NUMBER: 0001628280-24-000294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hasnain Faheem
CENTRAL INDEX KEY: 0001352620
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 24508772
MAIL ADDRESS:
STREET 1: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wk-form4_1704323893.xml
FORM 4
X0508
4
2023-12-29
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001352620
Hasnain Faheem
C/O MIRATI THERAPEUTICS, INC
3545 CRAY COURT
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2023-12-29
4
A
0
9702
58.75
A
24752
D
Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
/s/ John Moriarty, Attorney-in-Fact
2024-01-03